In order to investigate the translational potential of targeting USP8 in HCC, we tested the efficacy of a specific USP8 inhibitor: USP8i (9-ehtyloxyimino9H-indeno[1,2-b] pyrazine-2,3-dicarbonitrile) [13, 20]. The gene discussed is USP8; the disease is hepatocellular carcinoma.